Bright Therapeutics San Francisco, California, United States
Abstract Body The evolution of digital therapeutics represents a significant shift in the treatment of eating disorders (ED), providing a critical complement to in-person care. These tools provide a robust capability in integrating cognitive and behavioral therapy methods for patient benefit. One such app, Recovery Record, has seen more than 76.2 million evidence-based entries, such as thought logs and meal logs, recorded by its 1.1 million users to date. These users have also completed 1.3 million standardized outcome measures (such as the EPSI, PHQ-9 and GAD-7), data which can be used for in depth research into the symptomatology, comorbidity, and progression of ED in different populations. This presentation aims to further dissect the digital therapeutics landscape, utilizing Recovery Record as a case study to highlight the profound implications for clinical care.
Demographic data reveals that 86% of app users identify as female, 8% as male, and 6% as non-binary, with an average age of 28, reflecting the diverse nature of individuals engaging with digital ED treatments. Notably, 20% of users have disclosed experiencing disordered eating for the first time through the app, an indication of the reach digital tools can have to previously silent populations. Recovery Record has been used by over 31,000 clinicians and they have linked with patients across all 50 states and in over 40 countries worldwide. The in-app interactions and messages sent by clinicians can also be used to gain new insights into how therapeutic alliance affects clinical outcomes.
Beyond clinical outcomes, a recent study linking usage of the app with healthcare utilization found that within outpatient services, a significant decrease in acute care utilization was observed; patients utilizing the app showed fewer inpatient admissions and a 3.8-fold reduction in Emergency Room visits over six months. Patients also demonstrated increased engagement, attending an average of 10 additional appointments in a half-year span, suggesting that the app may play a role in enhancing adherence to therapeutic regimens.
Overall, this presentation will critically evaluate data recorded from digital tools, and how through academic collaborations and real-world data analysis, the nuances of ED treatment can be explored further. Several ongoing research projects will be presented to show how the platform's data informs new therapeutic directions and the rapid translation of research into practice, with the goal of offering more personalized and efficacious care for those battling EDs around the globe.
.png)
